Colorectal carcinoma: Diagnostic, prognostic, and molecular features

Modern Pathology

Volumn 16, Issue 4, 2003, Pages 376-388

  Compton, Carolyn C ^a,b  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Circumferential margin; Colon cancer; Grade; Microsatellite instability; Pathology; Prognostic factors; Rectal cancer; TNM stage

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL;

CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CHROMOSOME 18; COLORECTAL CARCINOMA; DRUG RESPONSE; HETEROZYGOSITY LOSS; HISTOLOGY; HUMAN; IMMUNE RESPONSE; METASTASIS; MICROSATELLITE INSTABILITY; PATHOLOGY; PATIENT CARE; PERINEURIUM; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; QUALITY CONTROL; RECTOSCOPY; REPRODUCIBILITY; REVIEW; STANDARDIZATION; TUMOR BIOPSY; TUMOR IMMUNITY;

COLORECTAL NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MOLECULAR DIAGNOSTIC TECHNIQUES; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0037393449     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MP.0000062859.46942.93     Document Type: Review

References (61)

1. Fleming ID, Cooper JS, Henson DE, et al., editors. AJCC manual for staging of cancer. 5th ed. Philadelphia, PA: Lippincott-Raven; 1997.
2. Nelson H, Petrelli N, Carlin A, et al. Guidelines for colon and rectal cancer surgery. J Natl Cancer Inst 201;93:583-96.
3. Greene FL, Balch CM, Fleming ID, et al., editors. AJCC manual for staging of cancer. 6th ed. New York: Springer Verlag; 2002.
4. Compton CC, Fielding LP, Burgart LJ, et al. Prognostic factors in colorectal cancer: College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000;124:979-94.
5. Compton CC, Fenoglio-Preiser CM, Pettigrew N, Fielding LP. American Joint Committee on Cancer Prognostic Factors consensus conference: Colorectal Working Group. Cancer 2000;88:1739-57.
6. Hamilton SR, Rubio CA, Vogelstein B, et al. Carcinoma of the colon and rectum. In: Hamilton SR, Aaltonen LA, editors. World Health Organization classification of tumours. Tumours of the digestive system. Lyon, France: IARC Press; 2000. p. 101-19.
7. Compton CC. Updated protocol for the examination of specimens removed from patients with colorectal carcinoma. Arch Pathol Lab Med 2000;124:1016-25.
8. Jass JR, Do K-A, Simms LA, Iino H, Wynter C, Pillay SP, et al. Morphology of sporadic colorectal cancer with DNA replication errors. Gut 1998;42:673-9.
9. Messerini L, Vitelli F, DeVitis LR, et al. Microsatellite instability in sporadic colorectal carcinomas: relationship to clinico-pathological variables. J Pathol 1997;182:380-4.
10. Jesserun J, Romero-Guadarrama M, Manivel JC. Medullary adenocarcinoma of the colon: clinicopathologic study of 11 cases. Hum Pathol 1999;30:843-8.
11. Mulcahy HE, Skelly MM, Husain A, et al. Long-term outcome following curative surgery for malignant large bowel obstruction. Br J Surg 1996;83:46-50.
12. DeBruine A, Wiggers T, Beek C, et al. Endocrine cells in colorectal adenocarcinomas: incidence, hormone profile and prognostic relevance. Int J Cancer 1993;54:765-71.
13. Gaffey M, Mills S, Lack E. Neuroendocrine carcinoma of the colon and rectum. A clinicopathologic, ultrastructural, and immunohistochemical study of 24 cases. Am J Surg Pathol 1990;14:1010-23.
14. Goldstein NS, Hart J. Histologic features associated with lymph node metastasis in stage T1 and superficial T2 rectal adenocarcinomas in abdominoperineal resections. Identifying a subset of patients for whom treatment with adjuvant therapy or completion abdominoperineal resection should be considered after local excision. Am J Clin Pathol 1999;111:51-8.
15. Shepherd N, Baxter K, Love S. The prognostic importance of peritoneal involvement in colonic cancer: a prospective evaluation. Gastroenterology 1997;112:1096-102.
16. Zeng Z, Cohen AM, Hajdu S, et al. Serosal cytologic study to determine free mesothelial penetration of intraperitoneal colon cancer. Cancer 1992;70:737-40.
17. Wittekind C, Henson DE, Hutter RVP, Sobin LH, editors. TNM supplement. A commentary on uniform use. 2nd ed. New York: Wiley-Liss; 2001.
18. Herrera-Ornelas L, Justiniano J, Castillo N, et al. Metastases in small lymph nodes from colon cancer. Arch Surg 1987;122:1253-6.
19. Scott KWM, Grace RH. Detection of lymph node metastases in colorectal carcinoma before and after fat clearance. Br J Surg 1989;76:1165-7.
20. Tepper JE, O'Connell MJ, Niedzwiecki D, et al. Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol 2001;19:157-63.
21. Blenkinsopp WK, Stewart-Brown S, Blesovsky L, et al. Histopathology reporting in large bowel cancer. J Clin Pathol 1981;34:509-13.
22. Bernini A, Spencer M, Frizelle S, et al. Evidence for colorectal cancer micrometastases using reverse transcriptase-polymerase chain reaction analysis of MUC2 in lymph nodes. Cancer Detect Prev 2000;24:72-9.
23. Liefers GJ, Tollenaar RA, Cleton-Jansen AM. Molecular detection of minimal residual disease in colorectal and breast cancer. Histopathology 1999;34:385-90.
24. Liefers GI, Cleton-Jansen AM, van de Velde CJ, et al. Micrometastases and survival in stage II colorectal cancer. N Engl J Med 1998;339:223-8.
25. Yasuda K, Adachi Y, Shiraishi N, et al. Pattern of lymph node micrometastasis and prognosis of patients with colorectal cancer. Ann Surg Oncol 2001;8:300-4.
26. Clarke G, Ryan E, O'Keane JC, et al. The detection of cytokeratins in lymph nodes of Duke's B colorectal cancer subjects predicts a poor outcome. Eur J Gastroenterol Hepatol 2000;12:549-52.
27. Clarke G, Ryan E, Crowe J, et al. Immunohistochemical detection of mutant p53 protein in regional lymph nodes is associated with adverse outcome in stage II colorectal cancer. Eur J Histochem 1999;43:311-6.
28. Isaka N, Nozue M, Doy M, Fukao K. Prognostic significance of perirectal lymph node micrometastases in Dukes' B rectal carcinoma: an immunohistochemical study by CAM5.2. Clin Cancer Res 1999;5:2065-8.
29. Greenson JK, Isenhart CE, Rice R, et al. Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival. Cancer 1994;73:563-9.
30. Clarke GA, Ryan E, Crowe JP, et al. Tumour-derived mutated K-ras. Int J Colorectal Dis 2001;16:108-11.
31. Tschmelitsch J, Klimstra DS, Cohen AM. Lymph node micrometastases do not predict relapse in stage II colon cancer. Ann Surg Oncol 2000;7:601-8.
32. Nakanishi Y, Ochiai A, Yamauchi Y, et al. Clinical implications of lymph node micrometastases in patients with colorectal cancers. A case control study. Oncology 1999;57:276-80.
33. Oberg A, Stenling R, Tavelin B, Lindmark G. Are lymph node micrometastases of any clinical significance in Dukes Stages A and B colorectal cancer? Dis Colon Rectum 1998;41:1244-9.
34. Adell G, Boeryd B, Franlund B, et al. Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes' B colorectal carcinoma: an immunohistochemical study. Eur J Surg 1996;162:637-42.
35. Wittekind C, Compton CC, Sobin LH. Residual tumour classification revisited. Cancer 2002;94:2511-6.
36. Cross SS, Bull AD, Smith JHF. Is there any justification for the routine examination of bowel resection margins in colorectal adenocarcinoma? J Clin Pathol 1989;42:1040-2.
37. Sloane JP, Ansell ID, Quirke P, Underwood JCE. Standards and minimum datasets for reporting common cancers. Minimum dataset for colorectal cancer histopathology reports. London: The Royal College of Pathologists; 1998.
38. Quirke P. Limitations of existing systems of staging for rectal cancer: the forgotten margin. In: Rajagopalan NT, editor. Rectal cancer research. New York: Springer-Verlag; 2001. p. 63-81.
39. Quirke P, Scott N. The pathologist's role in the assessment of local recurrence in rectal carcinoma. Surg Oncol Clin N Am 1992;3:1-17.
40. Quirke P, Durdy P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Lancet 1986;II:996-9.
41. Adam IJ, Mohamdee MO, Martin IG, et al. Role of the circumferential margin involvement in the local recurrence of rectal cancer. Lancet 1994;344:707-11.
42. Chan K, Boey J, Wong S. A method of reporting radial invasion and surgical clearance of rectal carcinoma. Histopathology 1985;9:1319-27.
43. Stacchi L, Nelson H, Sargent DJ, et al. Impact of surgical and pathological variables in rectal cancer: a United States community and cooperative group report. J Clin Oncol 2001;19:3895-902.
44. Nagtegaal ID, van der Worp E, van de Velde CJ, et al. Macroscopic evaluation of rectal cancer resection specimens: clinical significance of the pathologist in quality control. J Clin Oncol 2002;20:1729-34.
45. Compton CC. The pathology report in colon cancer: what's prognostically important? Dig Dis 1999;17:67-79.
46. Jass J, Atkin W, Cuzick J, et al. The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases. Histopathology 1986;10:437-59.
47. Hase K, Shatney C, Johnson D, et al. Prognostic value of tumor "budding" in patients with colorectal cancer. Dis Colon Rectum 1993;36:627-35.
48. Jass JR, Do KA, Simms LA, et al. Morphology of sporadic colorectal cancer with DNA replication errors. Gut 1998;42:673-9.
49. Alexander J, Watanabe T, Wu TT, et al. Histopathological identification of colon cancer with microsatellite instability. Am J Pathol 2001;158:527-35.
50. Jen I, Kim H, Piantadosi S, et al. Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med 1994;331:213-21.
51. Laurent-Puig P, Olschwang S, Delattre O, et al. Survival and acquired genetic alterations in colorectal cancer. Gastroenterology 1992;102:1136-41.
52. Cohn KH, Ornstein DL, Wang F, et al. The significance of allelic deletions and aneuploidy in colorectal carcinoma. Cancer 1997;79:233-44.
53. Carethers JM, Hawn JK, Greenson JK, et al. Prognostic significance of allelic loss at chromosome 18q21 for stage II colorectal cancer. Gastroenterology 1998;114:1188-95.
54. Gryfe R, Kim H, Hsieh ET, et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 2000;342:69-77.
55. Sankila R, Aaltonen LA, Jarvinen HJ, Mecklin JP. Better survival rates in patients with MLH1-associated hereditary colorectal cancer. Gastroenterology 1996;110:682-7.
56. Watanabe T, Wu TT, Catalano PJ, Ueki T. Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med 2001;344:1196-206.
57. Guidoboni M, Gafa R, Viel A, Doglioni C. Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis. Am J Pathol 2001;159:297-304.
58. Samowitz WS, Curtin K, Ma KN, Schaffer D. Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol Biomarkers Prev 2001;10:917-23.
59. Berger SH, Jenh CH, Johnson LF, Berger FG. Thymidylate synthase overproduction and gene amplification in fluorodeoxyuridine-resistant human cells. Mol Pharmacol 1985;28:461-7.
60. Swain SM, Lippman ME, Egan EF, et al. Fluorouracil and high doses leucovorin in previously treated patients with metastatic breast cancer. J Clin Oncol 1989;7:890-9.
61. Leichman L, Lenz H-J, Leichman CG, et al. Quantitation of intratumoral thymidylate synthase expression predicts for resistance to protracted infusion of 5-fluorouracil and weekly leucovorin in disseminated colorectal cancers: preliminary report from an ongoing trial. Eur J Cancer 1995;31:1306-10.